Endocrinology Group
Rheumatology Group
Department of Endocrinology and Rheumatology
-Endocrinology Group
01What we do

Director
Hiroyuki Murabe
The endocrinology department was established in 1966 at this hospital when radioisotope diagnostic testing and radioiodine treatment commenced for Graves’ disease. We began high-dose radioisotope therapy in 1994, and also began radioiodine therapy for cancer of the thyroid gland.
Our team soon gained more and more new specialist staff and we branched into the treatment of endocrine conditions other than those of the thyroid, including conditions of the pituitary, adrenal, and parathyroid glands. Improved diagnostic investigation techniques have allowed for the earlier diagnosis and commencement of therapy. Our patient demographic is widespread, from the eastern part of Hiroshima Prefecture and throughout Okayama Prefecture. We also participate in each medical society as a specialist institution and undertake training of physicians including residents
02Conditions handled in this department
Conditions of the thyroid gland
- Graves’ Disease
- Chronic thyroiditis (Hashimoto Disease), hypothyroidism
- Thyroid nodule
- Thyroid cancer
- Graves’ orbitopathy (opthalmopathy)
Conditions of the adrenal gland
- Adrenal Incidentaloma
- Pheochromocytoma
- Cushing’s syndrome
- Primary aldosteronism
Conditions of the pituatary gland
- Pituitary tumor
- Acromegaly
- Prolactinoma
- Hypopituitarism
- Central diabetes insipidus
Conditions of the Parathyroid gland, disorders of calcium metabolism
- Primary hyperparathyroidism
- Hypercalcemia
Diabetes, metabolic disease
- Diabetes, hyperlipedemia, hyperproteinuria
- Metabolic syndrome
Department of Endocrinology, Metabolism and Rheumatology
-Rheumatology Group
01What we do
The rheumatology section treats rheumatoid arthritis and other rheumatoid disorders (ankylosing spondylitis, psoriatic arthritis, crystal-induced arthritis, etc.) We also deal with diseases of connective tissue and any related conditions (systemic lupus erythematosus, scleroderma, dermatomyositis, polymyositis, vasculitic syndrome, mixed connective tissue disease, Behcet’s disease, Sjorgen’s syndrome, polymyalgia rheumatica, etc.).
We also experience a lot of patient presentations with difficult to diagnose fever, after infection has been eliminated as a possible diagnosis. Endocrine diseases have been known to be hard to treat and incurable, but recent advancements in medicine have made early diagnosis a possibility and treatment more effective, resulting in an improving prognosis. The side-effect and complication profiles of treatments are also improving, and treatment outcomes have improved vastly over time.
02Main Conditions Treated in this Department
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Polymyositis, dermatomyositis
- Scleroderma (systemic sclerosis)
- Mixed connective tissue disease
- Vasculitic syndrome